Side effects of atypical antipsychotics: a brief overview
about
Amphetamines versus placebo for schizophreniaSchizophrenia: redox regulation and volume neurotransmissionVitamin D Levels in Different Severity Groups of Schizophrenia.Classics in Chemical Neuroscience: Aripiprazole.Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapyThe efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate.Schizophrenia gene expression profile reverted to normal levels by antipsychoticsBrain in flames - animal models of psychosis: utility and limitationsGender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medicationsCardiologic side effects of psychotropic drugs.Perinatal Generalized Anxiety Disorder: Assessment and Treatment.Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medicationsRepurposing antipsychotics as glioblastoma therapeutics: Potentials and challengesAtypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.Pedal edema associated with atypical antipsychotics.International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities.A psychiatric-cardiac case: analysis for education and clinical practice.Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (-141 C Ins/Del) and 5HTR2C (-759 C>T) Genetic Polymorphisms in Patients with Schizophrenia.Olanzapine long-acting injection: a review of its use in the treatment of schizophrenia.Sertindole for the treatment of schizophrenia.Treatment-emergent adverse events associated with atypical antipsychotics.Clinical management considerations for dyslipidemia in HIV-infected individuals.Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials.Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.Atypical antipsychotics and effects on feeding: from mice to men.Effects of antipsychotics on intestinal motility in zebrafish larvae.Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment options.Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability.Priapism in antipsychotic drug use: a rare but important side effect.A comprehensive analysis of mitochondrial genes variants and their association with antipsychotic-induced weight gainWeight changes before and after lurasidone treatment: a real-world analysis using electronic health records.In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact.Psychotropic medication use in children with autism in the Kentucky Medicaid population.Regulation of macrophage immune responses by antipsychotic drugs.Cultural diversity in physical diseases among patients with mental illnesses.Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients.An interactive SAR approach to discover novel hybrid thieno probes as ligands for D2-like receptors with affinities in the subnanomolar range.
P2860
Q24186797-392A1B0A-ED2A-461F-ADB6-FEC838A3A2B0Q28742799-174FB822-E70E-42BB-9845-6AD91F983737Q33790336-C4C79D8B-0C31-46DE-8E59-DCA9BE4C35B4Q33866125-0B427734-3697-4576-A052-224847CC76F6Q34686544-F3FA8755-741B-4E77-92FD-6FE039AF7BCBQ34988703-7986E6E5-7E19-4470-B6BF-7C7694E6AE45Q35100107-95D74232-4756-46FA-8065-16E24CA5006BQ35179019-BFADFE01-3925-4C4E-BD1F-F993BB519CC4Q35683865-E9E72D1E-486F-441B-94F7-169441D94C92Q36060797-48729662-3677-43EA-88C6-FF8EFFA300F6Q36077336-F6256A92-9466-46FF-A948-7F35B5892F17Q36108616-A8E362D5-AFB0-458D-98E7-3D6EA2340F43Q36279100-6EC27B1D-0511-4AD3-B265-8E48EA7DF435Q36524716-C72DEF2A-8294-46E6-A49F-EB33B0D8DF1CQ36588685-9EA469BE-5810-4DA9-B42A-A1A8DD63E1E8Q36651483-2C5207A8-F208-4049-A6C4-045B6776BF76Q37379161-F3F7F3E2-6DC4-49EE-856F-960D07ED74C8Q37508881-A5CDA31B-BE93-4BC4-92EE-8A93F55EE7ACQ37725986-18404E6F-DEB7-48ED-BAE0-86A203885BA9Q37809849-938A9CD9-B6F0-403F-8453-92EC34BA44D0Q37809874-A2EEB1A7-28F0-4251-9CE7-1A148FDCBFB5Q37981271-DB1897F4-EE89-4D14-BACB-3721AB466FBFQ37982205-85AD8285-ADFC-45AF-B9DB-D269FD1BBDFBQ38241344-D596D066-3F5A-4491-8E46-69FB8FEBBA9DQ38676860-E0ECA850-2475-42D5-BE86-1FED71B6CEECQ38758414-C329D733-8B24-4617-B591-CCD2C3B24D94Q38821689-9628E6BA-AA5E-4FF9-A89C-4A3D4F96AABDQ38850666-046677A8-9D16-4D2E-B4A2-54BDF3B371A3Q39095978-7B447709-0F5A-4CFE-B6A2-B56E98655FF3Q40410423-149275BF-0149-4FF6-A3FB-8101DC8A1EF9Q41387751-13D2FA71-4DC2-46FB-91DC-3199FDD53C2FQ42278672-0AB72B1C-EA02-48BE-9593-25898B7E2F3EQ42607272-532C2603-460C-4ED4-9BBD-5F76159A09F8Q42682470-19606DCA-C661-4E85-8D93-2F3CE7EEFC96Q43090127-E9FF1062-F2EB-41E5-80EA-5A6FA66A4259Q44691438-DD6D2452-B555-4F2B-BFA1-F547CAEC87D5Q44755614-16A82BAF-994E-4992-B399-24119B5654EEQ45140327-B745E568-C1A3-4D13-8833-F4188DA8C90AQ46138357-86FF4E56-2459-4BB4-90CD-32D4F6CA76CDQ46170154-DEF48956-B355-41DD-A86F-958046DA8412
P2860
Side effects of atypical antipsychotics: a brief overview
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Side effects of atypical antipsychotics: a brief overview
@ast
Side effects of atypical antipsychotics: a brief overview
@en
Side effects of atypical antipsychotics: a brief overview
@nl
type
label
Side effects of atypical antipsychotics: a brief overview
@ast
Side effects of atypical antipsychotics: a brief overview
@en
Side effects of atypical antipsychotics: a brief overview
@nl
prefLabel
Side effects of atypical antipsychotics: a brief overview
@ast
Side effects of atypical antipsychotics: a brief overview
@en
Side effects of atypical antipsychotics: a brief overview
@nl
P2860
P3181
P1433
P1476
Side effects of atypical antipsychotics: a brief overview
@en
P2093
P2860
P3181
P356
10.1002/J.2051-5545.2008.TB00154.X
P407
P577
2008-02-01T00:00:00Z